We are live on ! Find out more
IMUC

ImmunoCellular Therapeutics, Ltd.
IMUC

Delisted

IMUC was delisted on the 16th of October, 2018.

31 hedge funds and large institutions have $1.43M invested in ImmunoCellular Therapeutics, Ltd. in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 6

14% less funds holding

Funds holding: 3631 (-5)

49% less capital invested

Capital invested by funds: $2.77M → $1.43M (-$1.34M)

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
31
Holders Change
-5
Holders Change %
-13.89%
% of All Funds
0.83%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
6
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Nomura Holdings
26
Nomura Holdings
Japan
-$5K -554 Closed
RJA
27
Raymond James & Associates
Florida
-$3K -380 Closed
Creative Planning
28
Creative Planning
Kansas
-$1K -100 Closed
Bank of America
29
Bank of America
North Carolina
+$270 +42 +156%